Onabotulinumtoxin-a during COVID-19 pandemic: Long-term efficacy in chronic migraine

por Locatelli, Martina, Di Cola, Francesca Schiano, Caratozzolo, Salvatore, Liberini, Paolo, Rao, Renata, Padovani, Alessandro
Publicado 2021

Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine

por di Cola, Francesca Schiano, Bolchini, Marco, Caratozzolo, Salvatore, Ceccardi, Giulia, Cortinovis, Matteo, Liberini, Paolo, Rao, Renata, Padovani, Alessandro
Publicado 2023

Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence

por Labastida-Ramírez, Alejandro, Benemei, Silvia, Albanese, Maria, D’Amico, Antonina, Grillo, Giovanni, Grosu, Oxana, Ertem, Devrimsel Harika, Mecklenburg, Jasper, Fedorova, Elena Petrovna, Řehulka, Pavel, di Cola, Francesca Schiano, Lopez, Javier Trigo, Vashchenko, Nina, MaassenVanDenBrink, Antoinette, Martelletti, Paolo
Publicado 2020

Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves

por Cristillo, Viviana, Pilotto, Andrea, Benussi, Alberto, Libri, Ilenia, Giunta, Marcello, Morotti, Andrea, Gipponi, Stefano, Locatelli, Martina, Piccinelli, Stefano Cotti, Mazzoleni, Valentina, di Cola, Francesca Schiano, Masciocchi, Stefano, Pezzini, Debora, Scalvini, Andrea, Premi, Enrico, Cottini, Elisabetta, Gamba, Massimo, Magoni, Mauro, Fontanella, Marco Maria, Padovani, Alessandro
Publicado 2022